NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...
More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...
The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name ...
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.